We sit down with two of our Field Application Scientists, Ashley Hart and Jenny Morse, to discuss the technical expertise they offer to OGT customers all over North America. And we chat with one of our customers, Kathleen Kretkowski, about a real-life example of OGT support in action.
Read articleWe sit down with two of our Field Application Scientists, Ashley Hart and Jenny Morse, to discuss the technical expertise they offer to OGT customers all over North America. And we chat with one of our customers, Kathleen Kretkowski, about a real-life example of OGT support in action.
ReadMyeloid malignancies are a group of diseases with wide heterogeneity. In this blog, we will explore the KMT2A gene, previously known as the MLL gene, and its influence upon myeloid malignancies.
ReadDesigning in situ probes for hybridization assays can be a tricky, time-consuming task. Read our blog to discover five tips for effective probe design!
ReadTina Stafki talks about how she got hooked on FISH early on in her career, how she uses FISH in the CellNetix pathology lab to help patients and clinicians across the Pacific Northwest, and why CytoCell FISH probes from OGT are her first choice when it comes to FISH probes.
ReadIs NGS set to become the new gold standard in constitutional genetics? Discover how NGS offers greater insight into indels, CNVs, LOH, mosaicism and more.
ReadAs one of the first steps in many NGS data analysis pipelines, accurate variant calling is often critical to downstream analysis and interpretation. Here, we take a look at variant calling best practice through a modern lens.
ReadA high-quality sequencing library is the linchpin to generating good sequencing data. We discuss our six top tips to help you improve your sequencing library.
ReadWe discuss the development and current state of sequencing technologies, and where the future of NGS may take us...
ReadFISH is a cytogenetic technique utilized in labs to detect chromosomal abnormalities in both cancer and constitutional specimens. In this blog learn about the advantages of FISH...
ReadThis blog will discuss FLT3’s normal function, its implications in myeloid malignancies, and the role of NGS in genetic identification and disease management of patients with FLT3 genetic alterations.
ReadWhile liquid biopsy may present an attractive alternative to a solid biopsy, it also has limitations. Here, we shed light on some advantages, limitations, and future outlook for liquid biopsy in oncology clinical practice.
ReadWith many of our team once being customers themselves, our scientists endeavor to create a portfolio shaped by a genuine understanding of its real-world clinical application. Meet Jackie Chan and Huiyan Jin, two of OGT’s Next Generation Sequencing (NGS) experts.
Read
Visit International site
Visit USA site
International
